Febuxostat Versus Allopurinol Control Trial in Subjects With Gout

PHASE3CompletedINTERVENTIONAL

Enrollment

760

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

February 29, 2004

Study Completion Date

February 29, 2004

Conditions

Gout

Interventions

DRUG

Febuxostat

Febuxostat 80 mg, orally, once daily for up to 52 weeks.

DRUG

Febuxostat

Febuxostat 120 mg, orally, once daily for up to 52 weeks.

DRUG

Allopurinol

Allopurinol 300 mg, capsules, orally, once daily for up to 52 weeks.